The medical industry briefing
The latest news, approvals and clinical trials you need to know about this month
News in Numbers
Deepmind’s AlphaFold program has been used to predict the structures of 350,000 proteins belonging to humans and other organisms.
Medical imaging company Nanox has partnered with EiLEENO Pharma to send 1,000 of its digital X-ray systems and companion cloud service software to Nigeria.
Using an automatic tool, a team from the School of Biomedical Engineering & Imaging Sciences at King’s College London were able to label more than 120,000 MRI images in less than 30 minutes.
The approximate number of personal protective equipment items that have been deemed unfit for use in clinical settings in the UK, according to the Commons Public Accounts Committee.
The number of children across England that are due to be assessed using a heel prick blood test to identify if they have a ‘faulty gene’ that causes familial hypercholesterolaemia.
New AI tech for early detection of prostate cancer
An artificial intelligence (AI) program developed at RMIT University in Melbourne, Australia could catch signs of prostate cancer earlier, allowing for incidental detection through routine computed tomography scans.
Source: Eureka Alert
Blood flow monitored with stretchable ultrasound patch
The new ultrasound patch developed at the University of California San Diego can continuously monitor blood flow, blood pressure and heart function in real-time. Wearing such a device could make it easier to identify the onset of cardiovascular problems.
Source: The Engineer
Medical devices industry tests UK plans for post-Brexit divergence
Hopes of the UK becoming a global innovation hub for new medical devices after Brexit will be stifled if the UK diverges from EU standards in search of a post-Brexit regulatory dividend, industry experts have warned.
Source: Financial Times
DNA origami to trap viruses inside body
Researchers at the Technical University of Munich have developed a method to create tiny virus traps that can bind viral particles and render them harmless within the body. The technique relies on DNA origami to create self-assembling hollow nanocapsules, which are lined with molecules that will bind viruses and prevent them from leaving.
Embracing Emerging Technologies
Italy-based AAVantgarde Bio is an innovative biotech start-up that is currently focused on developing gene therapies for inherited retinal disorders.
Source: AAVantgarde Bio
Echopoint Medical is a spinout company from University College London, UK, which develops optical sensing technology to help heart disease patients where the need for treatment is unclear.
Source: Echopoint Medical
Austrian start-up Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets.
Source: Celeris Therapeutics
US-based company Nines is a tele-radiology and artificial intelligence startup. Its product NinesAI is FDA-cleared to triage time-critical, life-threatening indications of mass effect and intracranial hemorrhage.
Biotechnology company Lucira Health offers disposable at-home test kits to detect infectious diseases, such as Covid-19.
Source: Lucira Health
US-based company Bloomlife is using technology, data science and medical expertise to address issues in maternal health.